At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


Clinical Trials

September 2, 2020

Rush University Medical Center is recruiting participants for a nationwide trial of a COVID-19 vaccine developed by the University of Oxford in England and AstraZeneca, a multinational pharmaceutical company. 

May 15, 2020

Patients with COVID-19 between the ages of 20 and 59 years old who also had asthma needed a ventilator to assist with breathing for five days more on average than non-asthmatic patients with COVID-19, according to researchers at Rush.

November 6, 2019

Neurologists from the Rush Parkinson’s Disease and Movement Disorders Program are working with a Chicago-area martial arts academy to launch a karate program designed to help people with Parkinson’s disease.

September 11, 2018

Rush is testing whether a vaccine can help people’s own immune system slow the spread of glioblastomas, a deadly form of brain cancer.

August 1, 2018

The William G. McGowan Charitable Fund has awarded Rush University Medical Center a $9 million grant to expand the Eat, Love, Move program to five cities.

August 30, 2017

Rush scientists are testing whether having a common genetic mutation makes Parkinson’s disease patients more likely to suffer cognitive decline after deep brain stimulation surgery.  

June 27, 2017

The number of cancer clinical trials at Rush doubled last year — from around 30 in early 2015 to nearly 150 by the end of 2016. And the focus of the research has broadened.

March 30, 2017

Preventive medicine experts at Rush University Medical Center have discovered that delaying access to tempting, high-calorie foods and snacks in vending machines potentially can shift people’s choices to purchase less desired, but healthier snack options. Results of this study will be presented at the Society of Behavioral Medicine’s Annual Meeting & Scientific Sessions being held in San Diego, California.

September 15, 2016

Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial.

July 18, 2016

A new clinical study may give hope to stroke victims who reach physicians past the six-hour time window of treatment from the time a stroke occurs.